InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Discover the complete record of transactions filed by Renz Justin A, Chief Financial Officer. Insider active across 1 companies, notably Ardelyx, INC.. In total, 13 disclosures have been logged. Total volume traded: €55k. The latest transaction was filed on 6 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€43,70971,794 shares@ €0.60880.0031% mcap78.9% of flow
Common Stock
SEC:0001567619-22-012557:0·
€9701,528 shares@ €0.63470.0001% mcap1.8% of flow
Common Stock
SEC:0001567619-22-011524:0·
€1,0661,800 shares@ €0.59240.0001% mcap1.9% of flow
Common Stock
SEC:0001567619-22-005665:0·
042,000 shares0
Common Stock
SEC:0001567619-22-001140·
042,000 shares0
Common Stock
SEC:0001567619-22-001140:0·
€566643 shares@ €0.87970.0000% mcap11.7% of flow
Common Stock
SEC:0001567619-21-021163·
€566643 shares@ €0.87970.0000% mcap1.0% of flow
Common Stock
SEC:0001567619-21-021163:0·
0250,000 shares0
Common Stock
SEC:0001567619-21-019029·
0250,000 shares0
Common Stock
SEC:0001567619-21-019029:0·
€713631 shares@ €1.13050.0001% mcap14.8% of flow
Common Stock
SEC:0001567619-21-016285·
€713631 shares@ €1.13050.0001% mcap1.3% of flow
Common Stock
SEC:0001567619-21-016285:0·
€3,548612 shares@ €5.79760.0002% mcap73.5% of flow
Common Stock
SEC:0001567619-21-010923·
€3,548612 shares@ €5.79760.0002% mcap6.4% of flow
Common Stock
SEC:0001567619-21-010923:0·
13 of 13 declarations
About Renz Justin A
Justin A. Renz is the Chief Financial Officer of ARDELYX, INC., where he oversees the company's financial operations. With expertise in financial management and corporate strategy, he plays a key role in financial planning and performance analysis. His leadership contributes to the growth and sustainability of ARDELYX, a company focused on developing innovative treatments for chronic diseases.
